-- ============================================================================
-- SURGERY 3 MCQ BATCH 30: Spleen and Adrenal Disorders (Questions 1741-1800)
-- Topic: Splenectomy, Splenic Disorders, Adrenal Tumors, Pheochromocytoma
-- ============================================================================

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES

-- Splenic Anatomy and Function (1-10)
('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'The spleen is supplied primarily by:',
'Inferior mesenteric artery', 'Splenic artery (branch of celiac trunk)', 'Superior mesenteric artery', 'Gastroduodenal artery', 'Left gastric artery',
'B', 'Splenic blood supply: Splenic artery (largest branch of celiac trunk). Tortuous course along superior border of pancreas. Terminal branches: multiple splenic branches entering hilum. Short gastric arteries to fundus. Left gastroepiploic artery. Venous drainage: splenic vein → joins SMV to form portal vein behind pancreatic neck. Reference: Standring S. Grays Anatomy. 2021.',
'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'The spleen performs which of the following functions:',
'Primarily digestive', 'Filtration of blood (removal of old RBCs, bacteria), immunologic function (antibody production, opsonization), and reservoir for platelets', 'Hormone production only', 'Bile production', 'Urine concentration',
'B', 'Splenic functions: (1) Filtration - removes senescent RBCs (120-day lifespan), Howell-Jolly bodies, bacteria (encapsulated organisms), (2) Immunologic - antigen presentation, antibody production (IgM), opsonization, (3) Reservoir - 30% of platelets, (4) Hematopoiesis - fetal life (extramedullary hematopoiesis can occur in pathologic states). Asplenia/hyposplenism → increased infection risk. Reference: Mebius RE. Nat Rev Immunol. 2005.',
'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Howell-Jolly bodies on peripheral blood smear indicate:',
'Normal finding', 'Splenic hypofunction or absence (asplenia)', 'Liver disease', 'Bone marrow failure', 'Iron deficiency',
'B', 'Howell-Jolly bodies: nuclear remnants in RBCs (normally removed by spleen). Presence indicates: (1) Asplenia (surgical, congenital, autosplenectomy - sickle cell), (2) Functional hyposplenism (celiac disease, inflammatory bowel disease, SLE). Other findings of asplenia: target cells, Heinz bodies, Pappenheimer bodies, acanthocytes, thrombocytosis. Indicates loss of splenic filtration function and increased infection risk. Reference: William BM. Am J Hematol. 2007.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Overwhelming post-splenectomy infection (OPSI) is most commonly caused by:',
'E. coli only', 'Encapsulated organisms, especially Streptococcus pneumoniae (most common), Haemophilus influenzae, and Neisseria meningitidis', 'Candida only', 'Viruses only', 'Parasites',
'B', 'OPSI: life-threatening infection in asplenic patients. Encapsulated bacteria (spleen normally clears via opsonization/phagocytosis): (1) Streptococcus pneumoniae (50-90% of OPSI), (2) Haemophilus influenzae type b, (3) Neisseria meningitidis. Also: Capnocytophaga canimorsus (dog bites), Babesia, malaria. OPSI: rapid onset (hours), fever, DIC, septic shock, 50-70% mortality. Lifetime risk 1-5%. Peak 2 years post-splenectomy but lifelong risk. Reference: Rubin LG. N Engl J Med. 2014.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Prevention of OPSI includes:',
'No preventive measures', 'Vaccination against encapsulated organisms (pneumococcal, meningococcal, Haemophilus) ideally before splenectomy, and patient education', 'Antibiotics forever in all patients', 'Observation only', 'No vaccines available',
'B', 'OPSI prevention: (1) Vaccination - pneumococcal (PPSV23, PCV13), meningococcal (ACWY, B), Haemophilus influenzae type b. Ideally 2 weeks BEFORE elective splenectomy; if emergency, 2 weeks AFTER. Revaccination per guidelines. (2) Patient education - fever emergency, seek immediate care, MedicAlert bracelet. (3) Prophylactic antibiotics - children (until age 5), first 2 years post-splenectomy or lifelong in high-risk; penicillin V or amoxicillin. (4) Standby antibiotics for self-treatment if delayed care. Reference: Rubin LG. N Engl J Med. 2014.',
'medium', 'knowledge'),

-- Indications for Splenectomy (11-25)
('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'The most common indication for elective splenectomy is:',
'Splenic abscess', 'Immune thrombocytopenic purpura (ITP) refractory to medical therapy', 'Splenic cyst', 'Lymphoma staging', 'Wandering spleen',
'B', 'Elective splenectomy indications: (1) ITP (most common) - refractory to steroids, IVIG, TPO agonists; response rate 60-80%. (2) Hereditary spherocytosis, (3) Hereditary elliptocytosis, (4) Thalassemia (hypersplenism), (5) Autoimmune hemolytic anemia, (6) Thrombotic thrombocytopenic purpura (refractory), (7) Splenic cysts/tumors, (8) Part of en-bloc resection (distal pancreatectomy, gastric cancer). Reference: Kumar S. Surg Clin North Am. 2021.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Hereditary spherocytosis is an indication for splenectomy because:',
'The spleen causes the disease', 'The spleen sequesters and destroys spherocytic RBCs, causing hemolysis; splenectomy eliminates hemolysis', 'The spleen makes antibodies', 'To prevent infection', 'For cosmetic reasons',
'B', 'Hereditary spherocytosis: defect in RBC membrane proteins (spectrin, ankyrin) → spherical, less deformable RBCs. Spleen traps and destroys spherocytes → chronic hemolysis, anemia, jaundice, splenomegaly, gallstones. Splenectomy: eliminates hemolysis (spherocytes still present but not destroyed), cures anemia. Indication: moderate to severe disease. Cholecystectomy if gallstones. Wait until age 5-6 (OPSI risk higher in young children). Reference: Bolton-Maggs PH. Br J Haematol. 2012.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Splenic trauma is managed with:',
'Immediate splenectomy for all', 'Non-operative management for hemodynamically stable patients with close monitoring; splenectomy for unstable patients or failed NOM', 'Observation only for all', 'No treatment', 'Antibiotics only',
'B', 'Splenic trauma management: (1) Hemodynamically unstable: operative management (splenectomy or splenorrhaphy). (2) Hemodynamically stable: non-operative management (NOM) - bed rest, serial exams, Hb monitoring, ICU. Success rate >90% for grade I-III, 75-85% grade IV. (3) Angioembolization for pseudoaneurysm, contrast blush, higher-grade injuries. Indications for surgery: hemodynamic instability, failed NOM, peritonitis. Reference: Stassen NA. J Trauma. 2012.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Splenic artery aneurysm is:',
'Extremely rare', 'The third most common abdominal aneurysm (after aortic and iliac), with rupture risk especially during pregnancy', 'Always symptomatic', 'Only in men', 'Benign',
'B', 'Splenic artery aneurysm (SAA): third most common intra-abdominal aneurysm. Demographics: 4:1 female predominance. Risk factors: multiparity (portal hypertension, increased splanchnic blood flow), portal hypertension, pancreatitis. Rupture risk: overall 2-10%, but significantly higher in pregnancy (25-50% mortality - mother and fetus). Treatment: repair if >2cm, symptomatic, pregnant/childbearing age, enlarging. Options: endovascular (coiling, stent), open surgical. Reference: Trastek VF. Surgery. 1982.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Accessory spleen (splenunculus) is found in approximately:',
'<1% of population', '10-30% of individuals, most commonly near the splenic hilum', '100%', '>80%', 'Only in pathologic conditions',
'B', 'Accessory spleen: small nodule of functional splenic tissue separate from main spleen. Found in 10-30% of individuals. Locations: splenic hilum (75%), splenocolic ligament, gastrosplenic ligament, omentum, mesentery, pelvis (rare). Significance: (1) May hypertrophy after splenectomy for hematologic conditions (recurrence), (2) Must be identified and removed during splenectomy for ITP, spherocytosis. Imaging: nuclear spleen scan, Tc-99m sulfur colloid. Reference: Beahrs JR. Ann Surg. 1980.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Splenic vein thrombosis is most commonly caused by:',
'Liver cirrhosis', 'Pancreatitis (acute or chronic) leading to isolated gastric varices', 'Trauma only', 'Infection only', 'Spontaneous',
'B', 'Splenic vein thrombosis: obstruction of splenic vein. Causes: (1) Pancreatitis (most common - 50%) - acute or chronic, pancreatic pseudocyst. (2) Pancreatic malignancy, (3) Hypercoagulable states. Consequence: isolated left-sided (sinistral) portal hypertension → gastric varices (short gastric collaterals) WITHOUT esophageal varices. Treatment: splenectomy (eliminates source of gastric varices) - curative. Important to distinguish from portal vein thrombosis (different management). Reference: Sakorafas GH. Am J Surg. 2000.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'The laparoscopic approach to splenectomy is preferred because:',
'No benefits', 'Reduced pain, shorter hospital stay, faster recovery, and fewer wound complications compared to open splenectomy', 'It is faster', 'Higher success rate', 'Lower cost only',
'B', 'Laparoscopic splenectomy advantages: (1) Less pain, (2) Shorter hospital stay (1-2 days vs 4-7), (3) Faster recovery, (4) Fewer wound complications, (5) Improved cosmesis, (6) Lower overall morbidity. Standard for elective splenectomy. Contraindications: massive splenomegaly (relative - hand-assist possible), hemodynamic instability (trauma), portal hypertension (relative). Techniques: lateral or anterior approach. Reference: Habermalz B. Surg Endosc. 2008.',
'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Splenic abscess is:',
'Common', 'Rare but serious, most often from hematogenous spread, presenting with fever and LUQ pain', 'Always asymptomatic', 'Only from trauma', 'Never requires surgery',
'B', 'Splenic abscess: rare (<1% of all abscesses). Causes: (1) Hematogenous spread (endocarditis - 10-20%, IV drug use, bacteremia), (2) Contiguous spread, (3) Infected splenic infarct (sickle cell, emboli), (4) Immunocompromised. Organisms: Staphylococcus, Streptococcus, Salmonella, polymicrobial. Presentation: fever, LUQ pain, splenomegaly. Diagnosis: CT (hypodense lesion, rim enhancement, gas). Treatment: antibiotics + drainage (percutaneous if unilocular, splenectomy if multilocular, ruptured, or failed drainage). Mortality 15-30%. Reference: Chang KC. J Microbiol Immunol Infect. 2006.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Hypersplenism is characterized by:',
'Normal blood counts', 'Splenomegaly with peripheral cytopenia(s) due to splenic sequestration and destruction, corrected by splenectomy', 'Small spleen', 'Elevated cell counts', 'Only thrombocytosis',
'B', 'Hypersplenism: syndrome of splenomegaly + peripheral cytopenia(s) + bone marrow hyperplasia + correction with splenectomy. Mechanism: increased splenic sequestration and destruction of blood cells. Causes: portal hypertension, hemolytic anemias, myeloproliferative disorders, storage diseases (Gaucher), infections (malaria). Cytopenias: thrombocytopenia most common, also anemia, leukopenia. Treatment: address underlying cause; splenectomy if severe symptomatic cytopenias. Reference: Warkentin TE. Blood Rev. 2003.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Wandering spleen (ptotic spleen) requires surgery when:',
'All cases', 'Symptomatic (pain, torsion) or complicated by torsion with ischemia', 'Never', 'Only in children', 'Only for cosmesis',
'B', 'Wandering spleen: ectopic spleen due to laxity/absence of splenic ligaments. Spleen migrates from LUQ. Risk: torsion (splenic pedicle twists) → ischemia, infarction. Presentation: chronic intermittent abdominal pain (intermittent torsion), acute abdomen (complete torsion). Diagnosis: CT/US - absent spleen in LUQ, mass elsewhere. Treatment: surgical - splenopexy if viable (create pouch/mesh), splenectomy if infarcted. Reference: Fiquet-Francois C. J Pediatr Surg. 2010.',
'medium', 'knowledge'),

-- Adrenal Disorders (26-60)
('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Adrenal incidentaloma is defined as:',
'Any symptomatic adrenal tumor', 'An adrenal mass ≥1cm discovered incidentally on imaging performed for unrelated reasons', 'Only malignant tumors', 'Tumors <5mm', 'Symptomatic mass',
'B', 'Adrenal incidentaloma: adrenal mass (≥1cm) discovered on imaging for unrelated indication. Prevalence: 3-7% of abdominal CT scans, increases with age. Most are benign, non-functional adenomas. Workup: (1) Assess functionality (biochemical tests for cortisol, aldosterone, catecholamines), (2) Assess malignancy risk (size, imaging characteristics). Management based on functional status and malignancy risk. Reference: Fassnacht M. Eur J Endocrinol. 2016.',
'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'All patients with adrenal incidentaloma should be screened for:',
'Nothing', 'Pheochromocytoma (catecholamine excess), hypercortisolism (Cushing), and primary aldosteronism if hypertensive', 'Thyroid disease only', 'Diabetes only', 'Infection',
'B', 'Adrenal incidentaloma workup: (1) Pheochromocytoma - plasma free metanephrines or 24-hour urine metanephrines/catecholamines. Must exclude before any intervention. (2) Hypercortisolism - overnight 1mg dexamethasone suppression test (autonomous cortisol). (3) Primary aldosteronism - if hypertensive or hypokalemic: aldosterone-renin ratio. Even non-functioning incidentalomas may have "subclinical" hormone excess. Reference: Fassnacht M. Eur J Endocrinol. 2016.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Imaging characteristics suggesting benign adrenal adenoma include:',
'Large size (>6cm)', 'Low unenhanced CT attenuation (<10 HU), homogeneous appearance, and rapid contrast washout (>50% at 10-15 minutes)', 'Irregular margins', 'Calcifications', 'Invasion',
'B', 'Benign adenoma imaging: (1) Size <4cm, (2) Unenhanced CT attenuation ≤10 HU (lipid-rich), (3) Homogeneous, well-defined, smooth margins, (4) Absolute contrast washout >60% (or relative >40%) at 10-15 minutes. Malignancy features: size >4-6cm, irregular margins, heterogeneous, high HU (>20), invasion, delayed washout, growth on serial imaging. Lipid-poor adenomas may need MRI (chemical shift imaging) or PET. Reference: Caoili EM. Radiology. 2002.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Indications for adrenalectomy in adrenal incidentaloma include:',
'All incidentalomas', 'Functioning tumors (any size), tumors >4cm, imaging features suspicious for malignancy, or significant growth', 'Size <1cm', 'Non-functioning tumors only', 'Age <30 only',
'B', 'Adrenalectomy indications: (1) Functional tumors (any size) - pheochromocytoma, aldosteronoma, cortisol-secreting. (2) Size >4cm (some use >4-6cm) - higher malignancy risk. (3) Imaging concerning for malignancy (heterogeneous, irregular, high HU, delayed washout). (4) Growth >1cm/year on surveillance. (5) Symptomatic. Non-functional tumors <4cm with benign imaging features: observation with repeat imaging (6-12 months, then yearly if stable). Reference: Zeiger MA. J Clin Endocrinol Metab. 2009.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Pheochromocytoma is characterized by:',
'Hypokalemia', 'Catecholamine-secreting tumor arising from chromaffin cells, classically causing paroxysmal hypertension, headache, sweating, and palpitations', 'Low blood pressure', 'Arising from adrenal cortex', 'No symptoms',
'B', 'Pheochromocytoma: catecholamine-secreting tumor from adrenal medulla chromaffin cells. Classic triad: episodic headache, sweating, tachycardia/palpitations + paroxysmal hypertension. "Rule of 10s": 10% bilateral, 10% malignant, 10% extra-adrenal (paraganglioma), 10% familial (now 30-40% hereditary - MEN2, VHL, SDH mutations, NF1). Diagnosis: plasma free metanephrines (most sensitive) or 24-hour urine. Treatment: surgical resection with alpha-blockade first. Reference: Lenders JW. Lancet. 2005.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Preoperative preparation for pheochromocytoma surgery includes:',
'No preparation needed', 'Alpha-blockade (phenoxybenzamine) started 10-14 days before surgery, followed by beta-blockade if tachycardic, with volume expansion', 'Beta-blockade first', 'Immediate surgery', 'Calcium channel blockers only',
'B', 'Pheochromocytoma preoperative preparation: (1) Alpha-blockade FIRST - phenoxybenzamine (non-selective, irreversible) or doxazosin (selective) started 10-14 days preop. Goal: normotension, orthostatic hypotension indicates adequate blockade. (2) Beta-blockade ONLY AFTER alpha-blockade established (prevents unopposed alpha-vasoconstriction causing hypertensive crisis). Use for tachycardia. (3) High-salt diet, volume expansion (alpha-blockade reveals volume depletion). Avoid: tricyclics, metoclopramide, opioids (precipitate crisis). Reference: Pacak K. Nat Clin Pract Endocrinol Metab. 2007.',
'hard', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Primary hyperaldosteronism (Conn syndrome) is characterized by:',
'Low aldosterone', 'Hypertension, hypokalemia (often), elevated aldosterone-renin ratio, and suppressed plasma renin', 'High renin levels', 'Only in elderly', 'Normal blood pressure',
'B', 'Primary hyperaldosteronism: autonomous aldosterone production. Most common cause of secondary hypertension (5-15% of hypertensives). Clinical: resistant hypertension, spontaneous hypokalemia (30-50%), metabolic alkalosis. Causes: aldosterone-producing adenoma (APA, 35%), bilateral adrenal hyperplasia (60%), rare (carcinoma, GRA). Diagnosis: elevated aldosterone-renin ratio (>30), confirmatory tests (salt loading, fludrocortisone suppression). Subtype differentiation: adrenal CT, adrenal vein sampling. Reference: Funder JW. J Clin Endocrinol Metab. 2016.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Adrenal venous sampling (AVS) is performed in primary hyperaldosteronism to:',
'Diagnose the condition', 'Differentiate between unilateral adenoma (surgical) and bilateral hyperplasia (medical management)', 'Replace CT imaging', 'Measure cortisol only', 'Treat the disease',
'B', 'Adrenal venous sampling: gold standard for subtype differentiation in primary hyperaldosteronism. Purpose: lateralize aldosterone source - unilateral (adenoma, surgery indicated, cure expected) vs bilateral (hyperplasia, medical management with MRA like spironolactone/eplerenone). CT may miss small adenomas or show non-functioning "incidentaloma." Technique: simultaneous catheterization of both adrenal veins, measure aldosterone and cortisol (confirms successful catheterization). Lateralization ratio >4:1 suggests unilateral disease. Reference: Funder JW. J Clin Endocrinol Metab. 2016.',
'hard', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Cushing syndrome caused by an adrenal tumor is treated with:',
'Medical therapy only', 'Adrenalectomy (laparoscopic preferred for adenoma)', 'Pituitary surgery', 'Radiation', 'Observation',
'B', 'Adrenal Cushing syndrome: autonomous cortisol from adrenal adenoma or carcinoma. Diagnosis: elevated 24-hour urinary free cortisol or late-night salivary cortisol, suppressed ACTH (ACTH-independent), failure to suppress with high-dose dexamethasone. Treatment: (1) Adenoma - laparoscopic unilateral adrenalectomy (curative), (2) Carcinoma - open adrenalectomy with en-bloc resection. Perioperative stress-dose steroids (contralateral adrenal suppressed). Gradual steroid taper postop. Reference: Nieman LK. J Clin Endocrinol Metab. 2015.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Adrenocortical carcinoma (ACC) is:',
'Common and benign', 'A rare, aggressive malignancy with poor prognosis, often presenting with large tumor and hormonal excess', 'Always non-functional', 'Easily cured', 'Only in children',
'B', 'Adrenocortical carcinoma: rare (1-2/million/year), highly aggressive. Presentation: 60% functional (Cushing, virilization, mixed), 40% non-functional (mass effect). Features at diagnosis: large size (>6cm), local invasion, metastases (40%). Imaging: heterogeneous, irregular, delayed washout. Staging: I-IV. Treatment: (1) Surgery - complete resection (R0) only curative option, (2) Mitotane (adrenolytic agent) - adjuvant and metastatic, (3) Chemotherapy for advanced. Prognosis: poor, 5-year survival 15-35%. Reference: Fassnacht M. Lancet Oncol. 2015.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'The laparoscopic approach to adrenalectomy is indicated for:',
'Only large tumors', 'Most adrenal tumors <6cm that are benign-appearing and functional adenomas', 'Only pheochromocytoma', 'Never appropriate', 'Adrenocortical carcinoma',
'B', 'Laparoscopic adrenalectomy: standard approach for most adrenal tumors. Indications: functional adenomas (aldosteronoma, cortisol-producing, small pheochromocytoma), non-functional adenomas with indications for surgery, tumors <6cm with benign features. Advantages: less pain, shorter stay, faster recovery, better visualization. Contraindications (relative): large tumors (>6cm controversial), suspected malignancy (ACC), local invasion - open approach preferred for oncologic resection with possible en-bloc resection. Reference: Porpiglia F. Eur Urol. 2016.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'MEN2A syndrome includes:',
'Pituitary adenoma', 'Medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism', 'Gastrinoma', 'Insulinoma', 'VIPoma',
'B', 'MEN2A: autosomal dominant, RET proto-oncogene mutation. Components: (1) Medullary thyroid carcinoma (MTC) - 100% penetrance, calcitonin-secreting, (2) Pheochromocytoma - 50% (bilateral 50%), (3) Primary hyperparathyroidism - 20-30% (multigland hyperplasia). Screening: genetic testing (RET), then targeted surveillance. Prophylactic thyroidectomy based on RET mutation. MEN2B: MTC, pheochromocytoma, mucosal neuromas, marfanoid habitus (more aggressive MTC, earlier onset). Reference: Wells SA. N Engl J Med. 2015.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Congenital adrenal hyperplasia (CAH) is most commonly caused by deficiency of:',
'11-beta hydroxylase', '21-hydroxylase, leading to cortisol deficiency, androgen excess, and possibly salt-wasting', '17-alpha hydroxylase', 'Aldosterone synthase', '3-beta hydroxysteroid dehydrogenase',
'B', 'CAH: group of autosomal recessive disorders of steroidogenesis. 21-hydroxylase deficiency most common (95%). Pathophysiology: impaired cortisol synthesis → elevated ACTH → adrenal hyperplasia, androgen excess. Forms: (1) Classic salt-wasting (severe) - cortisol and aldosterone deficiency, ambiguous genitalia in females, adrenal crisis in neonates. (2) Classic simple virilizing, (3) Non-classic (late-onset) - mild, presents with hirsutism/infertility. Diagnosis: elevated 17-hydroxyprogesterone. Treatment: glucocorticoid replacement, mineralocorticoid if salt-wasting. Reference: Speiser PW. J Clin Endocrinol Metab. 2010.',
'hard', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Adrenal insufficiency (Addisonian crisis) is treated with:',
'Insulin', 'Intravenous hydrocortisone (stress-dose steroids) and fluid resuscitation', 'Antibiotics only', 'Beta-blockers', 'Observation',
'B', 'Adrenal crisis: life-threatening. Causes: abrupt glucocorticoid withdrawal in chronic users, stress in undiagnosed Addison disease, pituitary apoplexy, bilateral adrenal hemorrhage (Waterhouse-Friderichsen - meningococcemia). Presentation: hypotension, shock (unresponsive to fluids/vasopressors), hypoglycemia, hyponatremia, hyperkalemia (if primary), altered mental status. Treatment: (1) IV hydrocortisone 100mg bolus then 50-100mg q6-8h, (2) Aggressive IV fluids (0.9% saline, dextrose), (3) Treat precipitant. Life-saving. Reference: Bornstein SR. J Clin Endocrinol Metab. 2016.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Neuroblastoma is:',
'An adult tumor', 'A pediatric malignancy arising from neural crest cells, often in the adrenal medulla, with variable prognosis based on age and biology', 'Always benign', 'Arising from cortex', 'Only in teenagers',
'B', 'Neuroblastoma: most common extracranial solid tumor in children, neural crest origin. Location: adrenal medulla (40%), sympathetic chain. Age: median 18 months, 90% <5 years. Presentation: abdominal mass, "blueberry muffin" skin lesions, opsoclonus-myoclonus, "raccoon eyes," hypertension. Markers: elevated urinary VMA/HVA (catecholamine metabolites). Unique: can spontaneously regress (especially infants, stage 4S). Prognosis: depends on age (<18 months better), stage, MYCN amplification (poor), histology. Treatment: surgery ± chemotherapy ± radiation based on risk stratification. Reference: Maris JM. Lancet. 2007.',
'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'After unilateral adrenalectomy for cortisol-secreting adenoma, patients require:',
'No special care', 'Glucocorticoid replacement (stress-dose perioperatively, then tapered) until HPA axis recovers', 'Immediate steroid cessation', 'Permanent steroids always', 'Mineralocorticoid only',
'B', 'Post-adrenalectomy for Cushing: contralateral adrenal suppressed by chronic excess cortisol. Perioperative: stress-dose hydrocortisone (surgical stress). Postoperative: maintenance glucocorticoids (hydrocortisone) with gradual taper. Recovery of HPA axis: months to years (average 6-18 months). Monitor with morning cortisol or ACTH stimulation test. Educate about adrenal insufficiency, sick-day rules, emergency steroid injection. Mineralocorticoids not needed (contralateral zona glomerulosa intact). Reference: Ritzel K. Eur J Endocrinol. 2015.',
'hard', 'knowledge'),

('c0000045-0000-0000-0000-000000000045', 'a0000003-0000-0000-0000-000000000003',
'Adrenal myelolipoma is:',
'Malignant', 'A benign tumor composed of mature fat and hematopoietic elements, usually discovered incidentally', 'Functional', 'Requires immediate surgery', 'Common in children',
'B', 'Adrenal myelolipoma: benign tumor containing mature fat and hematopoietic tissue (bone marrow elements). Incidental finding on imaging. Diagnosis: CT shows fat attenuation (negative HU), pathognomonic. Usually unilateral, non-functional. Management: observation (most). Surgery only if: large (>6-7cm, hemorrhage risk), symptomatic, diagnostic uncertainty. No malignant potential, no follow-up needed once diagnosed. Reference: Decmann A. Eur J Endocrinol. 2017.',
'easy', 'knowledge');

SELECT 'Surgery 3 MCQ Batch 30 (Spleen and Adrenal): 60 questions inserted' as status;
